Insulin pumps lead to better clinical outcomes compared with injection
Observational study compared rates of severe hypoglycaemia in diabetes patients using insulin pump and injection therapy.
Source: BSIP SA / Alamy Stock Photo
The use of insulin pumps in young patients with type 1 diabetes has increased substantially in the last decade, but the association with short-term diabetes complications is unclear.
Researchers carried out a population-based observational study to determine whether rates of severe hypoglycaemia and diabetic ketoacidosis were lower with insulin pump therapy compared with insulin injection therapy in children, adolescents and young adults with type 1 diabetes.
The researchers started by matching 9,814 young patients using pump therapy with 9,814 young patients using insulin therapy.
It was found that pump therapy was associated with lower rates of severe hypoglycaemia (9.55 vs 13.97 per 100 patient-years) and diabetic ketoacidosis (3.64 vs 4.26 per 100 patient years) compared with injection therapy and better glycaemic control during the most recent year of therapy.
The findings provide evidence for improved clinical outcomes associated with insulin pump therapy compared with injection therapy in young people with type 1 diabetes, the authors concluded in the Journal of the American Medical Association (10 October 2017).
Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20203965
Recommended from Pharmaceutical Press
All you need to know about prescribing or administering drugs via enteral feeding tubes. Over 400 drug monographs as well as facts to inform clinical decision making.£54.00
Now in its twelfth edition, Stockley’s Drug Interactions is still the most comprehensive and authoritative international source of drug interaction information.£240.00
Disease Management covers the diseases commonly encountered in primary care by system, with common therapeutic issues. Includes case studies and self-assessment sections.£54.00
This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.£48.00
Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.£40.00